BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22349123)

  • 1. Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: method validation and overcoming specific and non-specific binding at low concentrations.
    Xu XS; Demers R; Gu H; Christopher LJ; Su H; Cojocaru L; Boulton DW; Kirby M; Stouffer B; Humphreys WG; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():77-86. PubMed ID: 22349123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and sensitive LC-MS/MS assay for the determination of saxagliptin and its active metabolite 5-hydroxy saxagliptin in human plasma and its application to a pharmacokinetic study.
    Batta N; Pilli NR; Derangula VR; Vurimindi HB; Damaramadugu R; Yejella RP
    Drug Res (Stuttg); 2015 Mar; 65(3):133-40. PubMed ID: 24941084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a rapid UPLC-MS/MS method for quantification of saxagliptin in rat plasma and application to pharmacokinetic study.
    Gao JW; Yuan YM; Lu YS; Yao MC
    Biomed Chromatogr; 2012 Dec; 26(12):1482-7. PubMed ID: 22334441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of metformin, saxagliptin and 5-hydroxy saxagliptin simultaneously by hydrophilic interaction liquid chromatography - electrospray ionization mass spectrometry and its application to a bioequivalence study with a single-pill combination in human.
    Peng Y; Chang Q; Yang N; Gu S; Zhou Y; Yin L; Aa J; Wang G; Sun J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():109-117. PubMed ID: 29518719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS/MS analysis of metformin, saxagliptin and 5-hydroxy saxagliptin in human plasma and its pharmacokinetic study with a fixed-dose formulation in healthy Indian subjects.
    Shah PA; Shah JV; Sanyal M; Shrivastav PS
    Biomed Chromatogr; 2017 Mar; 31(3):. PubMed ID: 27508356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a gamma-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions.
    Gu H; Deng Y; Wang J; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(25):2319-26. PubMed ID: 20674522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of bentysrepinine (Y101) in rat plasma by liquid chromatography tandem mass spectrometry: application to pharmacokinetic study.
    Fan H; Li R; Gu Y; Si D; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():103-9. PubMed ID: 22366283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MS.
    Xu XS; Dueker SR; Christopher LJ; Lohstroh PN; Keung CF; Cao KK; Bonacorsi SJ; Cojocaru L; Shen JX; Humphreys WG; Stouffer B; Arnold ME
    Bioanalysis; 2012 Aug; 4(15):1855-70. PubMed ID: 22943617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a robust ultrafiltration-LC-MS/MS method for quantitative analysis of unbound vadimezan (ASA404) in human plasma.
    Li W; Lin H; Smith HT; Tse FL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1927-33. PubMed ID: 21680264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a liquid chromatography/mass spectrometry method for pharmacokinetic studies of OZ78, a fasciocidal drug candidate.
    Kirchhofer C; Keiser J; Huwyler J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2770-4. PubMed ID: 20829125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast simultaneous quantitative analysis of FTY720 and its metabolite FTY720-P in human blood by on-line solid phase extraction coupled with liquid chromatography-tandem mass spectrometry.
    Emotte C; Deglave F; Heudi O; Picard F; Kretz O
    J Pharm Biomed Anal; 2012 Jan; 58():102-12. PubMed ID: 22018890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry.
    Hua X; Fu YJ; Zu YG; Wu N; Kong Y; Li J; Peng X; Efferth T
    J Pharm Biomed Anal; 2010 Jun; 52(2):273-9. PubMed ID: 20116956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.
    Gu GZ; Xia HM; Pang ZQ; Liu ZY; Jiang XG; Chen J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):449-56. PubMed ID: 21251889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasma.
    Ghassabian S; Wright LA; Dejager AD; Smith MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 881-882():34-41. PubMed ID: 22197608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma and its application to a bioequivalence study.
    Patel BN; Sharma N; Sanyal M; Shrivastav PS
    J Pharm Biomed Anal; 2008 Jul; 47(3):603-11. PubMed ID: 18387768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study.
    Sala F; Zucchetti M; Bagnati R; D'Incalci M; Pace S; Capocasa F; Marangon E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3118-26. PubMed ID: 19695967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of penciclovir in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.
    Kanneti R; Bhavesh D; Paramar D; Shivaprakash R; Bhatt PA
    Biomed Chromatogr; 2011 Apr; 25(4):458-65. PubMed ID: 21374647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive LC-MS/MS method for determination of levamisole in human plasma: application to pharmacokinetic study.
    Tong L; Ding L; Li Y; Wang Z; Wang J; Liu Y; Yang L; Wen A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):299-303. PubMed ID: 21256094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An accurate, rapid and sensitive determination of tramadol and its active metabolite O-desmethyltramadol in human plasma by LC-MS/MS.
    Patel BN; Sharma N; Sanyal M; Shrivastav PS
    J Pharm Biomed Anal; 2009 Feb; 49(2):354-66. PubMed ID: 19062215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.